Epilepsy and Seizure News
The Campaign for a National Plan for Epilepsy Needs Your Help -
A future neurologist appeals for your support for the National Plan for Epilepsy to coordinate research and care to enable earlier diagnosis, better treatment, and hopefully a cure.
Seizure action plans: Management and educational tools in epilepsy care -
Historically, seizure action plans have focused on certain high-risk groups—such as people with drug-resistant epilepsy and people with a history of status epilepticus or seizure clusters. Neurology ...
Seizure action plans: More than management tools for epilepsy -
Newswise — Historically, seizure action plans have focused on certain high-risk groups — such as people with drug-resistant epilepsy and people with a history of status epilepticus or seizure clusters ...
INTERVIEW: Epilepsy Advocacy Network provides resources, plans fundraiser -
One in 26 people will develop epilepsy in their lifetime, and one 1 in 10 people will have a seizure. November is just around the corner, and that is Epilepsy Awareness Month. Carrie Jones and Kim ...
Seizure or epilepsy? Understanding the critical difference could save lives -
A sudden episode of shaking, confusion, or loss of awareness can be frightening - but does it mean epilepsy? Understanding the difference between a seizure and epilepsy is crucial for timely treatment ...
What to do in the first 2 minutes of someone else's seizure -
The First Thing You Do Is Nothing Dramatic Do not grab them. Do not try to stop the shaking. Do not hold their arms down or pin their legs. The convulsion is a wave of electrical misfiring across the ...
First seizure clinic provides visit, pediatric epilepsy diagnosis in less than a week -
Please provide your email address to receive an email when new articles are posted on . The model expedites access to specialists after a first seizure. The mean time between the referral and the ...
Medical News Today
PubMed
Exploring the roles of ghrelin and nesfatin-1 as potential biomarkers in human epilepsy: a systematic review -
CONCLUSIONS: Ghrelin and nesfatin-1 exhibit dynamic changes in relation to the type of epilepsy, seizure activity, and treatment. These neuropeptides may serve as non-invasive biomarkers and therapeutic targets, with near-term clinical potential for monitoring adverse side effects of ASM, differentiating between seizure types, and predicting drug resistance. However, validation studies are need...
First seizure referral clinics or first seizure units in neurology: How long is too long? -
No abstract
Early neurocognitive outcomes following SEEG with radiofrequency thermocoagulation -
OBJECTIVE: Characterization of early neuropsychological outcomes following SEEG with radiofrequency thermocoagulation (RFTHC) is essential to guide patient expectations around return to work, study, and caregiving. The current study aimed to describe the early neurocognitive sequelae of SEEG.
Validation of the diagnosis of Lennox-Gastaut syndrome: Challenges and lessons learned -
OBJECTIVE: Lennox-Gastaut Syndrome (LGS) is a severe developmental and epileptic encephalopathy characterized by multiple seizure types, cognitive impairment, and distinct electroencephalographic (EEG) findings. However, evolving diagnostic criteria, heterogeneous clinical features, and inconsistent electronic health record (EHR) documentation complicate accurate diagnosis and cohort identifica...
Beyond neuroprotection: Context-dependent effects of GLP-1 receptor agonists on seizure susceptibility -
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely used in type 2 diabetes mellitus and obesity and are increasingly considered to exert neuroprotective effects. Recent large-scale clinical and real-world studies report a predominantly neutral to protective association between GLP-1 RA use and seizure- or epilepsy-related diagnoses. However, how these agents affect neuronal excita...
The translational asymmetry of corpus callosotomy: Two literatures that answered different questions -
Corpus callosotomy is an established palliative operation for drug-resistant epilepsy dominated by drop attacks, and it is performed in three extents: anterior, usually of the anterior two-thirds; total, in one or two stages; and selective posterior, which preserves the genu and rostral body. Meta-analysis finds no difference between them in overall seizure reduction, a difference in drop attac...
Science Daily